PEPID Achieves Meaningful Use Stage 2 Certification

March 24, 2015 — PEPID  has announced its leading drug interaction checker and drug allergy checker are now certified to help eligible hospitals and providers achieve the Stage 2 meaningful use measures under the American Reinvestment and Recovery Act (ARRA).

When employed as a module within any electronic health record system (EHR), PEPID’s drug interaction checker can cross reference any combination of a patient’s medications and alternative medicines and alert the provider if a potential interaction exists, promoting patient safety. PEPID’s drug-allergy checker cross references a patient’s allergies, and can also alert the provider if a potential sensitivity exists.

“PEPID is proud to achieve this certification so that we can continue to help hospitals and providers meet meaningful use criteria in electronic medical records,” says John Wagner, PEPID president.  “This certification will help our customers to get the most out of their healthcare technology investments.”

Electronic Health Record (EHR) module (version 1.0.3.71) — which includes PEPID’s drug interaction checker and drug allergy checker — is 2014 Edition-compliant and was certified as EHR Module (certification numbers IG-2967-13-0013 and IG-2967-13-0015). The certification and testing was conducted by InfoGard, an ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services.

PEPID’s Electronic Health Record modular certification, confirmed for both ambulatory and inpatient settings, satisfies the 2014 criteria and supports the Stage 2 meaningful use measures to qualify eligible providers and hospitals under the American Reinvestment and Recovery Act (ARRA).

PEPID certifications include:

  • §170.314(a)(2) - drug-allergy, drug-allergy interaction checks
  • §170.314(g)(3) - safety-enhanced design

Those attending the HIMSS Annual Conference April 12-15, 2015, in Chicago are encouraged to stop by PEPID booth #3144 to see a demonstration.

The PEPID EHR Module is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. To view the certifications, click here .

# # #

Contact: Amber Bryan
Email: press@pepid.com

About PEPID

PEPID utilizes cutting-edge technology to deliver clinical decision-support resources specific for healthcare professionals, primarily pharmacists, doctors, nurses, EMTs and students. PEPID content is reviewed and contributed to by partners including the American Academy of Emergency Medicine, the National Association of Emergency Medical Services Educators, the Family Physician Inquiries Network, the National Association of Clinical Nurse Specialists, the Oncology Nursing Society, and the American Society of Health-System Pharmacists to ensure content is of the highest quality.

Like us on Facebook: http://www.facebook.com/pepidllc
Follow us on Twitter: http://www.twitter.com/pepid_llc

Tags:

About Us

PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available. PEPID contains the most extensive drug database on the market today, along with thousands of disease profiles and medical conditions, medical and dosing calculators, a drug interactions checker, illustrations, laboratory values and a differential diagnosis generator. All PEPID’s clinical decision support data and tools can be integrated into any healthcare information system, EMR, EHR or EDIS to help meet requirements for meaningful use.

Subscribe

Documents & Links

Quick facts

The leading drug interaction checker and drug allergy checker are now certified to help eligible hospitals and providers achieve the Stage 2 meaningful use measures under the American Reinvestment and Recovery Act (ARRA).
Tweet this
PEPID’s Electronic Health Record modular certification, confirmed for both ambulatory and inpatient settings, satisfies the 2014 criteria and supports the Stage 2 meaningful use measures to qualify eligible providers and hospitals under the American Reinvestment and Recovery Act (ARRA).
Tweet this

Quotes

PEPID is proud to achieve this certification so that we can continue to help hospitals and providers meet meaningful use criteria in electronic medical records
John Wagner, President
This certification will help our customers to get the most out of their healthcare technology investments
John Wagner, President